NEW YORK (GenomeWeb) – San Diego-based Diagnomics will begin offering comprehensive and customized pharmacogenetic test reports through a strategic partnership with Translational Software.
The PGx analysis will be performed on Illumina's Global Screening Array and a comprehensive report on how the detected markers are likely to impact the patient's drug response, metabolism, and treatment efficacy will be generated using Translational Software's platform.